Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 01-2024 | 10-2023 | 07-2023 | 04-2023 | 01-2023 | |
| Sales | 8,553 | 7,806 | 8,959 | 7,485 | 7,514 |
| Cost of Goods | 4,329 | 4,351 | 5,814 | 4,476 | 4,616 |
| Gross Profit | 4,224 | 3,455 | 3,145 | 3,009 | 2,898 |
| Operating Expenses | 6,738 | 9,282 | 11,169 | 11,837 | 8,059 |
| Operating Income | -2,185 | -5,476 | -7,210 | -8,352 | -4,545 |
| Other Income | 1,322 | -199 | -1,669 | 455 | 1,653 |
| Pre-tax Income | -863 | -5,675 | -8,879 | -7,897 | -2,892 |
| Net Income Continuous | -863 | -5,675 | -8,879 | -7,897 | -2,892 |
| Net Income Discontinuous | -2,198 | -941 | 66,309 | -7,290 | -8,428 |
| Net Income | $-3,061 | $-6,616 | $57,430 | $-15,187 | $-11,320 |
| EPS Basic Total Ops | -0.06 | -0.13 | 1.17 | -0.31 | -0.23 |
| EPS Basic Continuous Ops | -0.02 | -0.11 | -0.18 | -0.16 | -0.06 |
| EPS Basic Discontinuous Ops | -0.04 | -0.02 | 1.35 | -0.15 | -0.17 |
| EPS Diluted Total Ops | -0.06 | -0.13 | 1.17 | -0.31 | -0.23 |
| EPS Diluted Continuous Ops | -0.02 | -0.11 | -0.18 | -0.16 | -0.06 |
| EPS Diluted Discontinuous Ops | -0.04 | -0.02 | 1.35 | -0.15 | -0.17 |
| EPS Diluted Before Non-Recurring Items | 0.00 | -0.11 | N/A | N/A | N/A |
| EBITDA(a) | $-1,918 | $-5,206 | $-6,604 | $-7,704 | $-3,919 |